Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-04-06 Sale |
2023-04-06 6:19 pm |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
13,280 | $6.12 | $81,274 | 136,720 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-04 Exercise |
2025-04-07 4:11 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 112,377 (Direct) |
View |
2025-04-04 Tax Withholding |
2025-04-07 4:11 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,355 | $0.675 | 112,377 (Direct) |
View |
2025-02-04 Option Award |
2025-02-05 4:31 pm |
N/A 2035-02-04 |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
200,000 | $0 | 200,000 (Direct) |
View |
2025-01-04 Tax Withholding |
2025-01-07 4:15 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,859 | $1.39 | 115,732 (Direct) |
View |
2025-01-04 Exercise |
2025-01-07 4:15 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 115,732 (Direct) |
View |
2024-10-04 Tax Withholding |
2024-10-07 4:10 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,349 | $2 | 119,591 (Direct) |
View |
2024-10-04 Exercise |
2024-10-07 4:10 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 119,591 (Direct) |
View |
2024-07-04 Exercise |
2024-07-08 4:02 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 122,940 (Direct) |
View |
2024-07-04 Tax Withholding |
2024-07-08 4:02 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,347 | $3.6 | 122,940 (Direct) |
View |
2024-06-07 Option Award |
2024-06-10 6:00 pm |
N/A 2034-06-06 |
Protara Therapeutics Inc. | TARA | Huang Jane Director |
10,000 | $0 | 10,000 (Direct) |
View |
2024-04-04 Tax Withholding |
2024-04-08 4:11 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,347 | $4.74 | 126,287 (Direct) |
View |
2024-04-04 Exercise |
2024-04-08 4:11 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 126,287 (Direct) |
View |
2024-03-01 Option Award |
2024-03-04 6:01 pm |
N/A 2034-02-28 |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
175,000 | $0 | 175,000 (Direct) |
View |
2024-01-04 Exercise |
2024-01-08 5:00 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 129,634 (Direct) |
View |
2024-01-04 Tax Withholding |
2024-01-08 5:00 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,844 | $3.77 | 129,634 (Direct) |
View |
2023-10-04 Exercise |
2023-10-06 09:07 am |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 133,478 (Direct) |
View |
2023-07-04 Exercise |
2023-07-06 4:35 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
9,375 | $0 | 133,478 (Direct) |
View |
2023-07-04 Tax Withholding |
2023-07-06 4:35 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
3,242 | $4.65 | 133,478 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 4:10 pm |
N/A 2033-06-06 |
Protara Therapeutics Inc. | TARA | Huang Jane Director |
10,000 | $0 | 10,000 (Direct) |
View |
2023-04-04 Exercise |
2023-04-06 6:19 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
37,500 | $0 | 136,720 (Direct) |
View |
2023-02-07 Option Award |
2023-02-09 4:07 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
150,000 | $0 | 150,000 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 4:10 pm |
N/A 2032-06-07 |
Protara Therapeutics Inc. | TARA | Huang Jane Director |
10,000 | $0 | 10,000 (Direct) |
View |
2022-05-02 Option Award |
2022-05-04 5:46 pm |
N/A 2032-04-30 |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
610,000 | $0 | 610,000 (Direct) |
View |
2021-12-14 Exercise |
2021-12-16 5:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 371,331 (Direct) |
View |
2021-12-14 Exercise |
2021-12-16 5:50 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 371,331 (Direct) |
View |
2021-11-30 Option Award |
2021-12-02 6:21 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
15,869 | $0 | 0 (Direct) |
View |
2021-11-17 Exercise |
2021-11-19 6:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 376,011 (Direct) |
View |
2021-11-17 Exercise |
2021-11-19 6:18 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 376,011 (Direct) |
View |
2021-10-19 Exercise |
2021-10-21 5:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $119.96 | 395,511 (Direct) |
View |
2021-10-19 Exercise |
2021-10-21 5:37 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 395,511 (Direct) |
View |
2021-09-20 Exercise |
2021-09-22 6:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
6,000 | $119.96 | 415,011 (Direct) |
View |
2021-09-20 Exercise |
2021-09-22 6:15 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
78,000 | $0 | 415,011 (Direct) |
View |
2021-08-31 Option Award |
2021-09-02 8:39 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
15,374 | $0 | 0 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
6,914 | $160.4 | 974,206 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
5,255 | $174.43 | 974,206 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
8,831 | $119.96 | 974,206 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
273,000 | $0 | 974,206 (Direct) |
View |
2021-06-29 Exercise |
2021-06-30 4:49 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 506,236 (Direct) |
View |
2021-06-29 Exercise |
2021-06-30 4:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 506,236 (Direct) |
View |
2021-06-16 Option Award |
2021-06-21 4:45 pm |
N/A 2031-06-15 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
182,546 | $0 | 157,196 (Direct) |
View |
2021-06-09 Option Award |
2021-06-10 9:35 pm |
N/A 2031-06-08 |
Protara Therapeutics Inc. | TARA | Huang Jane Director |
30,000 | $0 | 30,000 (Direct) |
View |
2021-05-28 Exercise |
2021-06-02 4:40 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 227,075 (Direct) |
View |
2021-05-28 Exercise |
2021-06-02 4:40 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 227,075 (Direct) |
View |
2021-05-31 Option Award |
2021-06-02 4:40 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
7,729 | $0 | 227,075 (Direct) |
View |
2021-04-29 Exercise |
2021-05-03 4:35 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 532,158 (Direct) |
View |
2021-04-29 Exercise |
2021-05-03 4:35 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 532,158 (Direct) |
View |
2021-03-29 Exercise |
2021-03-31 4:46 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 551,658 (Direct) |
View |
2021-03-29 Exercise |
2021-03-31 4:46 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 551,658 (Direct) |
View |
2021-02-26 Exercise |
2021-03-02 4:52 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 571,158 (Direct) |
View |
2021-02-26 Exercise |
2021-03-02 4:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 571,158 (Direct) |
View |
2021-01-29 Exercise |
2021-02-02 4:49 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 590,658 (Direct) |
View |
2021-01-29 Exercise |
2021-02-02 4:49 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 590,658 (Direct) |
View |
2020-12-29 Exercise |
2020-12-30 4:34 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 610,158 (Direct) |
View |
2020-12-29 Exercise |
2020-12-30 4:34 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 610,158 (Direct) |
View |
2020-11-30 Exercise |
2020-12-02 5:01 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 629,658 (Direct) |
View |
2020-11-30 Exercise |
2020-12-02 5:01 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 629,658 (Direct) |
View |
2020-10-29 Exercise |
2020-11-02 4:44 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 649,158 (Direct) |
View |
2020-10-29 Exercise |
2020-11-02 4:44 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 649,158 (Direct) |
View |
2020-09-29 Exercise |
2020-10-01 4:52 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 668,658 (Direct) |
View |
2020-09-29 Exercise |
2020-10-01 4:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 668,658 (Direct) |
View |